Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Advanced Endometrial Carcinoma · Recurrent Endometrial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

    Contact: Study coordinator (Site Public Contact) · gingerreeves@uabmc.edu
    Contact: Principal Investigator (Michael D. Toboni)
  • Alaska Women's Cancer Care, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8100
    Contact: Principal Investigator (Joseph T. Beck)
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Heather R. Williams)
  • Highlands Oncology Group - Rogers, Rogers, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Highlands Oncology Group, Springdale, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Mercy Cancer Center - Carmichael, Carmichael, California, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Mercy San Juan Medical Center, Carmichael, California, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@commonspirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Mercy Cancer Center - Elk Grove, Elk Grove, California, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Koji Matsuo)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Koji Matsuo)
  • Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · ccto-office@stanford.edu · 650-498-7061
    Contact: Principal Investigator (Kristin L. Bixel)
  • Eisenhower Medical Center, Rancho Mirage, California, United States

    Contact: Study coordinator (Site Public Contact) · 760-834-3798
    Contact: Principal Investigator (Mark Genesen)
  • Mercy Cancer Center - Rocklin, Rocklin, California, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Mercy Cancer Center - Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Nancy T. Nguyen)
  • Woodland Memorial Hospital, Woodland, California, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-365-2406
    Contact: Principal Investigator (Bradley R. Corr)
  • Memorial Hospital North, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-364-6700
    Contact: Principal Investigator (Bradley R. Corr)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Bradley R. Corr)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Bradley R. Corr)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Bradley R. Corr)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Bradley R. Corr)
  • Hartford Hospital, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-545-5363
    Contact: Principal Investigator (Amy K. Brown)
  • Hartford HealthCare - Manchester, Manchester, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Amy K. Brown)
  • The Hospital of Central Connecticut, New Britain, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-224-5660
    Contact: Principal Investigator (Amy K. Brown)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Kristen Starbuck)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Kristen Starbuck)
  • Augusta University Medical Center, Augusta, Georgia, United States

  • Emory Decatur Hospital, Decatur, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrialsoncology@dekalbmedical.org · 440-778-1868
    Contact: Principal Investigator (Kristen Starbuck)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Emma Barber)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer_Studies@rush.edu · 312-226-2371
    Contact: Principal Investigator (Alexander C. Cohen)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Emma Barber)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Emma Barber)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Emma Barber)
  • Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer_Studies@rush.edu · 312-226-2371
    Contact: Principal Investigator (Alexander C. Cohen)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Emma Barber)
  • OSF Saint Francis Medical Center, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Emma Barber)
  • Goshen Center for Cancer Care, Goshen, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cccois@goshenhealth.com · 574-364-2973
    Contact: Principal Investigator (Pamela J. Stone)
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · research@stvincent.org · 317-338-2194
    Contact: Principal Investigator (Megan E. Buechel)
  • Memorial Hospital of South Bend, South Bend, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 800-284-7370
    Contact: Principal Investigator (LaToya J. Perry)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Saint Anthony Regional Hospital, Carroll, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · sbenson@iora.org · 515-689-7658
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Hospital, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-365-4673
    Contact: Principal Investigator (Deborah W. Wilbur)
  • Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-363-2690
    Contact: Principal Investigator (Deborah W. Wilbur)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (David P. Bender)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 859-257-3379
    Contact: Principal Investigator (Rachel W. Miller)
  • West Jefferson Medical Center, Marrero, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • East Jefferson General Hospital, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • University Medical Center New Orleans, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 800-987-3005
    Contact: Principal Investigator (Sarah J. Sinclair)
  • MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@mainehealth.org · 207-396-8670
    Contact: Principal Investigator (Leslie S. Bradford)
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
    Contact: Principal Investigator (Amanda N. Fader)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Susana M. Campos)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Zhen Ni Zhou)
  • Bronson Battle Creek, Battle Creek, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • University of Michigan - Brighton Center for Specialty Care, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 800-865-1125
    Contact: Principal Investigator (Zhen Ni Zhou)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (J. R. Liu)
  • Hurley Medical Center, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (J. R. Liu)
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Bronson Methodist Hospital, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • West Michigan Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Beacon Kalamazoo Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 574-647-7370
    Contact: Principal Investigator (Kathleen Y. Butler)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (J. R. Liu)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Trinity Health Muskegon Hospital, Muskegon, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · connie.szczepanek@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Corewell Health Reed City Hospital, Reed City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Munson Medical Center, Traverse City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • University of Michigan Health - West, Wyoming, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Yan Ji)
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 573-882-7440
    Contact: Principal Investigator (Erin R. Tuller)
  • Mercy Hospital Springfield, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • CoxHealth South Hospital, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Lindsey A. McAlarnen)
  • Fred and Pamela Buffett Cancer Center - Kearney, Kearney, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Lindsey A. McAlarnen)
  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Brent J. Tierney)
  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Lindsey A. McAlarnen)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Lindsey A. McAlarnen)
  • Women's Cancer Center of Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · 702-851-4672
    Contact: Principal Investigator (Nicola M. Spirtos)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Eugenia Girda)
  • Rutgers New Jersey Medical School, Newark, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Eugenia Girda)
  • The Valley Hospital - Luckow Pavilion, Paramus, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrialsresearch@valleyhealth.com · 201-634-5792
    Contact: Principal Investigator (Eleonora Teplinsky)
  • Valley Health System Ridgewood Campus, Ridgewood, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrialsresearch@valleyhealth.com · 201-634-5792
    Contact: Principal Investigator (Eleonora Teplinsky)
  • Sidney Kimmel Cancer Center Washington Township, Sewell, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jessa Suhner)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Amaranta D. Craig)
  • Northwell Health Imbert Cancer Center, Bay Shore, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Veena S. John)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Northwell Health Physician Partners at Flushing, Flushing, New York, United States

    Contact: Study coordinator (Site Public Contact) · nhppflushing@northwell.edu · 718-559-3600
    Contact: Principal Investigator (Veena S. John)
  • Northwell Health Cancer Institute at Huntington, Greenlawn, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Veena S. John)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Veena S. John)
  • Manhattan Eye Ear and Throat Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-434-4460
    Contact: Principal Investigator (Veena S. John)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Lenox Hill Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Veena S. John)
  • Queens Cancer Center, Rego Park, New York, United States

    Contact: Study coordinator (Site Public Contact) · 718-312-3446
    Contact: Principal Investigator (Veena S. John)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Rachael Turner)
  • Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States

    Contact: Study coordinator (Site Public Contact) · 914-366-1600
    Contact: Principal Investigator (Veena S. John)
  • Staten Island University Hospital, Staten Island, New York, United States

    Contact: Study coordinator (Site Public Contact) · 718-226-8888
    Contact: Principal Investigator (Veena S. John)
  • Stony Brook University Medical Center, Stony Brook, New York, United States

    Contact: Study coordinator (Site Public Contact) · 800-862-2215
    Contact: Principal Investigator (Susan M. Lang)
  • State University of New York Upstate Medical University, Syracuse, New York, United States

    Contact: Study coordinator (Site Public Contact) · 315-464-5476
    Contact: Principal Investigator (Mary J. Cunningham)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Nicole S. Nevadunsky)
  • Montefiore Medical Center-Weiler Hospital, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Nicole S. Nevadunsky)
  • Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Nicole S. Nevadunsky)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Olivia D. Lara)
  • Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Duke University Medical Center, Durham, North Carolina, United States

  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 910-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 919-785-4878
    Contact: Principal Investigator (Jennifer L. McNally)
  • Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • OhioHealth O'Bleness Hospital, Athens, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Aultman Health Foundation, Canton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalReserachDept@aultman.com · 330-363-7274
    Contact: Principal Investigator (Sunitha Vemulapalli)
  • Geauga Hospital, Chardon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Floor Backes)
  • Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States

  • Riverside Methodist Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • Grant Medical Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • Doctors Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • Grady Memorial Hospital, Delaware, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • Columbus Oncology and Hematology Associates, Dublin, Ohio, United States

  • Dublin Methodist Hospital, Dublin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • OhioHealth Mansfield Hospital, Mansfield, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • OhioHealth Marion General Hospital, Marion, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • University Hospitals Parma Medical Center, Parma, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • OhioHealth Pickerington Methodist Hospital, Pickerington, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • ProMedica Flower Hospital, Sylvania, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · PCIOncResearch@promedica.org · 419-824-1842
    Contact: Principal Investigator (Anjalika Gandhi)
  • OhioHealth Westerville Medical Campus/Westerville Cancer Center, Westerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 610-788-3860
    Contact: Principal Investigator (Aine E. Clements)
  • UH Seidman Cancer Center at Saint John Medical Center, Westlake, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Grace Duininck)
  • Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · cancer@lhs.org · 800-220-4937
    Contact: Principal Investigator (Julia Fehniger)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Legacy Meridian Park Hospital, Tualatin, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · 503-413-1742
    Contact: Principal Investigator (Julia Fehniger)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Sarah E. Taylor)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Sarah E. Taylor)
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Sarah E. Taylor)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jessa Suhner)
  • Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jessa Suhner)
  • UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-2811
    Contact: Principal Investigator (Sarah E. Taylor)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Sarah E. Taylor)
  • UPMC Cancer Center-Washington, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Sarah E. Taylor)
  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jessa Suhner)
  • Women and Infants Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · 401-274-1122
    Contact: Principal Investigator (Paul A. DiSilvestro)
  • Vanderbilt-Ingram Cancer Center Cool Springs, Franklin, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Alaina J. Brown)
  • Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Alaina J. Brown)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Alaina J. Brown)
  • University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Talicia Savage)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Talicia Savage)
  • South Jordan Health Center, South Jordan, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Talicia Savage)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Linda R. Duska)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Jaclyn Wall)
  • Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Swedish Medical Center-First Hill, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Legacy Salmon Creek Hospital, Vancouver, Washington, United States

    Contact: Study coordinator (Site Public Contact) · 503-413-2150
    Contact: Principal Investigator (Julia Fehniger)
  • United Hospital Center, Bridgeport, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Krista S. Pfaendler)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Stephen H. Bush)
  • WVUH-Berkely Medical Center, Martinsburg, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Krista S. Pfaendler)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Krista S. Pfaendler)
  • Camden Clark Medical Center, Parkersburg, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Krista S. Pfaendler)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (Kurt Oettel)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Sheboygan Physicians Group, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Essentia Health-Spooner Clinic, Spooner, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Essentia Health Saint Mary's Hospital - Superior, Superior, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 701-364-6272
    Contact: Principal Investigator (Bret E. Friday)
Study leads
  • Amanda N Fader

    Principal Investigator

    NRG Oncology